Copy to clipboard 
Medbio acquired Polymer Conversions (PCI). Together, these businesses create a medical device manufacturing company, capable of supporting the rapid growth of the company’s customers. Medbio is a portfolio company of Graham Partners, a private investment firm targeting industrial technology and advanced manufacturing companies.
Headquartered in Western New York, Polymer Conversions is a full-service medical device contract manufacturer that specializes in complex thermoplastic injection molding and value-add assembly. PCI is highly complementary to the existing Medbio platform, expanding the company’s geographic presence, while creating cross-selling opportunities across a base of medical device customers.
The acquisition of PCI is also expected to present significant operational and commercial synergies as PCI joins Medbio. Chris Williams, Medbio CEO, said, “I’m looking forward to partnering with the PCI team to expand Medbio’s manufacturing capabilities, while reaching new customers and end markets.”
Based in Michigan, Medbio specializes in precision injection molding, assembly, packaging, project management and design support.
